Romiplostim
Nplate (romiplostim) is a protein pharmaceutical. Romiplostim was first approved as Nplate on 2008-08-22. It is used to treat thrombocytopenic purpura idiopathic in the USA. It has been approved in Europe to treat thrombocytopenic purpura idiopathic. The pharmaceutical is active against thrombopoietin receptor.
| Trade Name | Nplate |
|---|---|
| Common Name | Romiplostim |
| Indication | thrombocytopenic purpura idiopathic |
| Drug Class | Colony-stimulating factors |
